Skip to main content
. 2016 Jul 13;5(7):e003822. doi: 10.1161/JAHA.116.003822

Table 1.

Baseline Characteristics

Characteristics Current Study n=12 527 Not in Current Study n=5275 Overall Study n=17 802
Age, y 66 (60–71) 66 (61–71) 66 (60–71)
Female 4542 (36.3) 2259 (42.8) 6801 (38.2)
Rosuvastatin 6182 (49.4) 2719 (51.6) 8901 (50.0)
Race/ethnicity
White 10 251 (81.8) 2432 (46.1) 12 683 (71.3)
Black 886 (7.1) 1338 (25.4) 2224 (12.5)
Asian 184 (1.5) 99 (1.9) 283 (1.6)
Hispanic 1105 (8.8) 1156 (21.9) 2261 (12.7)
Other/unknown 99 (0.8) 250 (4.7) 349 (2.0)
Body mass index, kg/m2 28.4 (25.5–32.0) 28.1 (25.0–32.0) 28.4 (25.3–32.)
Systolic blood pressure, mmHg 134 (124–146) 134 (125–144) 134 (124–145)
Diastolic blood pressure, mmHg 80 (75–86) 80 (76–89) 80 (75–87)
Current smoker 1883 (15.0) 937 (17.8) 2820 (15.9)
Family history of premature coronary disease 1575 (12.6) 470 (9.0) 2045 (11.5)
Metabolic syndrome 4987 (40.4) 2329 (44.5) 7316 (41.6)
Fasting glucose, mg/dL 95 (88–102) 93 (86–101) 94 (88–102)
Hemoglobin A1c, % 5.7 (5.4–5.9) 5.7 (5.5–6.0) 5.7 (5.5–5.9)
High‐sensitivity C‐reactive protein, mg/L 4.1 (2.8–6.9) 4.7 (3.0–7.9) 4.3 (2.9–7.1)
LDL cholesterol, mg/dL 109 (95–119) 107 (91–118) 108 (94–119)
Total cholesterol, mg/dL 186 (170–200) 183 (165–198) 185 (169–200)
Triglycerides, mg/dL 116 (84–167) 122 (88–175) 118 (85–169)
HDL cholesterol, mg/dL 49 (41–60) 47 (39–58) 49 (40–60)

Values stated are median (25th–75th percentile) or n (%). Percentages may not add up because of rounding off. HDL indicates high‐density lipoprotein; LDL, low‐density lipoprotein.